諾禾致源(688315.SH):未來生物數據方面的研究將十分廣闊
格隆匯4月28日丨有投資者向諾禾致源(688315.SH)提問:未來公司如何深挖生物數據的價值,是否可能開展deepmind方面的研究,比如阿爾法預測蛋白結構或功能基因組學方面的研究?
諾禾致源回覆:未來生物數據方面的研究將十分廣闊。公司在提供測序服務的同時,逐步搭建規模化平台,並積累團隊相關能力。當公司能夠建立完善的規模化平台,進行大規模數據生產時,就能開始進行相應任務開發。相較於自主投入產生數據的方式,在提供服務過程中逐步建立數據平台的方式,獲取的數據類型更具多樣性。未來當平台內的數據足夠豐富,就能實現基因功能預測、靶點預測、分子通路構建、蛋白質功能預測。未來公司將會對數據進行分層,對基因數據、基因表達數據、基因調控數據進行不同類型研究。公司也在積極拓展蛋白質組學、代謝組學相關業務,搭建相應平台,未來還會進行多組學、多平台協同發展。但上述業務的實現還需要較長時間的積累和努力,未來業務的想象空間巨大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.